NDRG1 disruption alleviates cisplatin/sodium glycididazole-induced DNA damage response and apoptosis in ERCC1-defective lung cancer cells
- PMID: 29768183
- DOI: 10.1016/j.biocel.2018.05.003
NDRG1 disruption alleviates cisplatin/sodium glycididazole-induced DNA damage response and apoptosis in ERCC1-defective lung cancer cells
Erratum in
-
Erratum to "NDRG1 disruption alleviates cisplatin/sodiumlycididazole-induced DNA damage response and apoptosis in ERCC1-defective lung cancer cells" [Int. J. Biochem. Cell Biol. 100 (2018) 54-64].Int J Biochem Cell Biol. 2018 Nov;104:180. doi: 10.1016/j.biocel.2018.09.002. Epub 2018 Sep 11. Int J Biochem Cell Biol. 2018. PMID: 30217488 No abstract available.
Abstract
Background: Resistance to platinum-based chemotherapy becomes a major obstacle in lung cancer treatment. Compensatory activation of nucleotide excision repair (NER) pathway is the major mechanism accounting for cisplatin-resistance. We aimed at identifying additional regulators in NER-mediated chemoresistance in a hypoxic setting induced by sodium glycididazole (CMNa)-sensitized cisplatin chemotherapy of non-small cell lung cancer (NSCLC).
Methods: We performed an RNA-sequencing (RNA-Seq) analysis to identify the genes whose expression had been differentially regulated in NER-deficient cells that had been treated by cisplatin/CMNa. DNA damage, apoptosis, and correlational analysis between the differentially expressed gene and drug sensitivity were determined by Western blots, flow cytometry and Oncomine expression analysis.
Results: The stress response gene, NDRG1 (N-Myc downstream-regulated gene 1), was among the differentially expressed genes in NER-deficient cells upon treatment of cisplatin/CMNa. Downregulation of NDRG1 by ERCC1 (excision repair cross-complementing 1) could be a prevalent mechanism for drug resistance. Furthermore, lower NDRG1 level is observed in human lung cancer cells showing chemotherapeutic drug resistance compared with the drug-sensitive cells.
Conclusion: NDRG1 is an important modulator linking DNA damage response and hypoxia-related cellular stress response during the development of drug resistance to cisplatin/CMNa in lung cancer. Targeting both NDRG1 and ERCC1 may be a viable strategy for overcoming drug resistance in cancer therapy, and has significant clinical implications.
Keywords: CMNa; Chemotherapy; Cisplatin; Drug resistance; ERCC1; NDRG1; Nucleotide excision repair (NER) pathway; RNA-Seq.
Copyright © 2018. Published by Elsevier Ltd.
Similar articles
-
Integrative PDGF/PDGFR and focal adhesion pathways are downregulated in ERCC1-defective non-small cell lung cancer undergoing sodium glycididazole-sensitized cisplatin treatment.Gene. 2019 Apr 5;691:70-76. doi: 10.1016/j.gene.2018.12.028. Epub 2018 Dec 22. Gene. 2019. PMID: 30584903
-
Small interfering RNA-induced suppression of ERCC1 enhances sensitivity of human cancer cells to cisplatin.Biochem Biophys Res Commun. 2005 Feb 4;327(1):225-33. doi: 10.1016/j.bbrc.2004.12.008. Biochem Biophys Res Commun. 2005. PMID: 15629453
-
Lentivirus-Mediated RNAi silencing targeting ERCC1 reverses cisplatin resistance in cisplatin-resistant ovarian carcinoma cell line.DNA Cell Biol. 2015 Jul;34(7):497-502. doi: 10.1089/dna.2015.2805. Epub 2015 May 5. DNA Cell Biol. 2015. PMID: 25941922
-
Pharmacogenetics of platinum-based chemotherapy in non-small cell lung cancer: predictive validity of polymorphisms of ERCC1.Expert Opin Drug Metab Toxicol. 2018 Jan;14(1):17-24. doi: 10.1080/17425255.2018.1416095. Epub 2017 Dec 18. Expert Opin Drug Metab Toxicol. 2018. PMID: 29226731 Review.
-
Testing for excision repair cross-complementing 1 in patients with non-small-cell lung cancer for chemotherapy response.Expert Rev Mol Diagn. 2007 May;7(3):261-8. doi: 10.1586/14737159.7.3.261. Expert Rev Mol Diagn. 2007. PMID: 17489733 Review.
Cited by
-
Multifaceted and Intricate Oncogenic Mechanisms of NDRG1 in Head and Neck Cancer Depend on Its C-Terminal 3R-Motif.Cells. 2022 May 7;11(9):1581. doi: 10.3390/cells11091581. Cells. 2022. PMID: 35563887 Free PMC article.
-
Microsatellite instability states serve as predictive biomarkers for tumors chemotherapy sensitivity.iScience. 2023 Jun 7;26(7):107045. doi: 10.1016/j.isci.2023.107045. eCollection 2023 Jul 21. iScience. 2023. PMID: 37448561 Free PMC article.
-
Serum and Glucocorticoid-Inducible Kinase 1 (SGK1) in NSCLC Therapy.Pharmaceuticals (Basel). 2020 Nov 22;13(11):413. doi: 10.3390/ph13110413. Pharmaceuticals (Basel). 2020. PMID: 33266470 Free PMC article. Review.
-
Demethoxycurcumin-Loaded Chitosan Nanoparticle Downregulates DNA Repair Pathway to Improve Cisplatin-Induced Apoptosis in Non-Small Cell Lung Cancer.Molecules. 2018 Dec 5;23(12):3217. doi: 10.3390/molecules23123217. Molecules. 2018. PMID: 30563166 Free PMC article.
-
NDRG1 in Cancer: A Suppressor, Promoter, or Both?Cancers (Basel). 2022 Nov 22;14(23):5739. doi: 10.3390/cancers14235739. Cancers (Basel). 2022. PMID: 36497221 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical